Conference Day One

Tuesday July 30, 2024

7:15 am Check-in & Coffee

8:15 am Chair’s Opening Remarks

Unpacking 2024’s Successes & Anticipating the Next Challenges to Advance the Future of mRNA-Based Therapeutics & Vaccines

8:30 am CEOs’ Panel Discussion: Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster

  • Andrew Allen President, Chief Executive Officer & Co-Founder, Gritstone bio, Inc.
  • Nathaniel Wang Chief Executive Officer & Co-Founder, Replicate Bioscience
  • Alexander Zehnder Chief Executive Officer, CureVacSE
  • Joe Payne Founder & President & Chief Executive Officer, Arcturus Therapeutics
  • Sophia Lugo Co-Founder & Chief Executive Officer, Radar Therapeutics
  • Nicholas Valiante Co- Founder & Chief Scientific Officer, Innovac Therapeutics
  • Guillaume Pfefer Chief Executive Officer, Sail Biomedicines

9:30 am Clinical Safety & Impact of RNA Cell Therapy in Patients with Myasthenia Gravis

  • Chris Jewell Chief Scientific Officer, Cartesian Therapeutics New Data!

10:00 am Session Details TBD

  • Aaron Larsen Senior Director & Technical Head - Nucleic Acid Franchise, Resilience Inc

Synopsis

Right click on the image to save it to your computer.

10:30 am Morning Break & Speed Networking

Track 1: Discovery

Discovery

Chair: Amit Srivastava, Vice President, RNA Therapeutics Portfolio Enhancement, Orbital Therapeutics

Download the Full Event Guide for full details


Unlocking the Power of Next Generation Base Editors & Replicating mRNA for Pushing the Frontiers of mRNA 


11:30am Advancing Next Generation Gene Editing with Beam Therapeutics’ Proprietary Next Generation Base Editor

Download the Full Event Guide for full details

Giuseppe Ciaramella, President; Chief Executive Officer, Orbital Therapeutics New Data!


11:30am Multimodal Support of mRNA Therapeutic Development

Download the Full Event Guide for full details

Peter Chu, Chief Executive Officer, Eclipse Bio


12:30pm Enabling Single-Dose, Multivalent Vaccination Against Pathogens of High Consequence Using a Muscle-Localizing Nanocarrier-Formulated Replicating mRNA

Download the Full Event Guide for full details

Jesse Erasmus, Director, Virology, HDT Bio


1:00pm Accessing a Vast Design Space with a Modular High Throughput Platform for RNA Therapeutics & Vaccines

Download the Full Event Guide for full details

Jesse Erasmus, Director, Virology, HDT Bio


 

Track 2: Translation
Track 3: Clinical Development
Track 4: CMC

1:10 pm Lunch Networking Break & Tech Slam

Track 1: Discovery

Discovery


Advancing RNA Drug Development & Design with Next-Generation Discovery Platforms


2:15pm Introduction to Orna’s Proprietary IRES Discovery & Drug Design Platform for Durable & Sustainable circRNA Expression

Download the Full Event Guide for full details

Allen Horthota, Head of Platform, Orna Therapeutics New Data!


2:45pm Session Reserved For: Henovcom

Download the Full Event Guide for full details


3:15pm Development of an mRNA Platform to Fight Infectious Disease

Download the Full Event Guide for full details

George Thom, Director, Discovery Sciences - (IVEB) mRNA, AstraZeneca


Track 2: Translation
Track 3: Clinical Development
Track 4: CMC

3:45 pm Afternoon Networking Break & Poster Session

Track 1: Discovery

Discovery


Advancing Next Generation mRNA Drug Development with Optimized Lead Selection & Targeted Delivery to Supercharge


4:30pm mRNA-Based Transcription Factor Delivery to In Vivo Disease Models

Download the Full Event Guide for full details

Hanae Toyonoga, Manager, Discovery Accelerator, Astellas Pharma New Company!


5:00pm Shedding Light on dsRNA: Specific & Sensitive Detection Using Bioluminescence

Download the Full Event Guide for full details

Jamison Grailer, Senior Reserach Scientist, Promega


5:30pm Translation of a Novel mRNA Therapeutic in Immunology & Oncology

Download the Full Event Guide for full details

Ajan Reginald, Chief Executive Officer, Roquefort Therapeutics


Track 2: Translation
Track 3: Clinical Development
Track 4: CMC

6:00 pm Drinks Reception